Literature DB >> 15562234

Pioglitazone treatment of insulin resistance in a patient with Werner's syndrome.

Sachiko Hattori, Makiko Kasai, Takashi Namatame, Yoshiyuki Hattori, Kikuo Kasai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15562234     DOI： 10.2337/diacare.27.12.3021

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Sitagliptin improves postprandial hyperglycemia by inhibiting glucagon secretion in Werner syndrome with diabetes.

Authors:  Kaneyuki Watanabe; Kazuki Kobayashi; Minoru Takemoto; Ryoichi Ishibashi; Masaya Yamaga; Harukiyo Kawamura; Masaki Fujimoto; Takahiro Ishikawa; Shunichiro Onishi; Emiko Okabe; Peng He; Koutaro Yokote
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 2.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

3.  Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes.

Authors:  Takumi Kitamoto; Minoru Takemoto; Masaki Fujimoto; Takahiro Ishikawa; Shunichiro Onishi; Emiko Okabe; Ryoichi Ishibashi; Kazuki Kobayashi; Harukiyo Kawamura; Koutaro Yokote
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.